MxA mRNA quantification and disability progression in interferon beta-treated multiple sclerosis patients.

Even though anti-interferon beta (IFNβ) antibodies are the main determinants of IFNβ bioactivity loss and Myxovirus-resistance protein A (MxA) is the most established marker of IFNβ biological activity in IFNβ-treated multiple sclerosis patients, their usefulness in the routine clinical practice is...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Federico Serana, Luisa Imberti, Maria Pia Amato, Giancarlo Comi, Claudio Gasperini, Angelo Ghezzi, Vittorio Martinelli, Leandro Provinciali, Maria Rosa Rottoli, Stefano Sotgiu, Sergio Stecchi, Michele Vecchio, Mauro Zaffaroni, Cinzia Cordioli, Ruggero Capra
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Public Library of Science (PLoS) 2014-01-01
Edice:	PLoS ONE
On-line přístup:	http://europepmc.org/articles/PMC3986392?pdf=render
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!